Incidence of Cancer and Mortality Following α-Tocopherol and β-Carotene Supplementation: A Postintervention Follow-up
The DOI matches its Crossref record.
Abstract
CONTEXT: In the Finnish Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study, alpha-tocopherol supplementation decreased prostate cancer incidence, whereas beta-carotene increased the risk of lung cancer and total mortality. Postintervention follow-up provides information regarding duration of the intervention effects and may reveal potential late effects of these antioxidants. OBJECTIVE: To analyze postintervention effects of alpha-tocopherol and beta-carotene on cancer incidence and total and cause-specific mortality. DESIGN, SETTING, AND PARTICIPANTS: Postintervention follow-up assessment of cancer incidence and cause-specific mortality (6 years [May 1, 1993-April 30, 1999]) and total mortality (8 years [May 1, 1993-April 30, 2001]) of 25 563 men. In the ATBC Study, 29 133 male smokers aged 50 to 69 years received alpha-tocopherol (50 mg), beta-carotene (20 mg), both agents, or placebo daily for 5 to 8 years. End point information was obtained from the Finnish Cancer Registry and the Register of Causes of Death. Cancer cases were confirmed through medical record review. MAIN OUTCOME MEASURES: Site-specific cancer incidence and total and cause-specific mortality and calendar time-specific risk for lung cancer incidence and total mortality. RESULTS: Overall posttrial relative risk (RR) for lung cancer incidence (n = 1037) was 1.06 (95% confidence interval [CI], 0.94-1.20) among recipients of beta-carotene compared with nonrecipients. For prostate cancer incidence (n = 672), the RR was 0.88 (95% CI, 0.76-1.03) for participants receiving alpha-tocopherol compared with nonrecipients. No late preventive effects on other cancers were observed for either supplement. There were 7261 individuals who died by April 30, 2001, during the posttrial follow-up period; the RR was 1.01 (95% CI, 0.96-1.05) for alpha-tocopherol recipients vs nonrecipients and 1.07 (95% CI, 1.02-1.12) for beta-carotene recipients vs nonrecipients. Regarding duration of intervention effects and potential late effects, the excess risk for beta-carotene recipients was no longer evident 4 to 6 years after ending the intervention and was primarily due to cardiovascular diseases. CONCLUSIONS: The beneficial and adverse effects of supplemental alpha-tocopherol and beta-carotene disappeared during postintervention follow-up. The preventive effects of alpha-tocopherol on prostate cancer require confirmation in other trials. Smokers should avoid beta-carotene supplementation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Kamangar, F., Dores, G. M., & Anderson, W. F. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2308 · Cited by 3,434
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577
“ATBC, 1994 (38, 39) Finland Smokers 100 57 50 Linxian Study B, 1993 (40) China Esophageal dysplasia 44 54 60”
Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2007) · JAMA · doi:10.1001/jama.297.8.842 · Cited by 2,275
Kushi, L. H., Byers, T., Doyle, C., Bandera, E. V., McCullough, M., Gansler, T., Andrews, K. S., Thun, M. J., & The American Cancer Society 2006 Nutrition and Physical Activity Guidelines Advisory Committee (2006) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.5.254 · Cited by 1,901
Kushi, L. H., Doyle, C., McCullough, M., Rock, C. L., Demark‐Wahnefried, W., Bandera, E. V., Gapstur, S., Patel, A. V., Andrews, K., Gansler, T., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20140 · Cited by 1,325
Lee, I.-M., Cook, N. R., Gaziano, J. M., Gordon, D., Ridker, P. M., Manson, J. E., Hennekens, C. H., & Buring, J. E. (2005) · JAMA · doi:10.1001/jama.294.1.56 · Cited by 1,137
Alberg, A. J., & Samet, J. M. (2010) · Murray and Nadel's Textbook of Respiratory Medicine · doi:10.1016/b978-1-4160-4710-0.00046-8 · Cited by 1,060
Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007176.pub2 · Cited by 924
Alberg, A. J., Brock, M. V., & Samet, J. M. (2016) · Murray and Nadel's Textbook of Respiratory Medicine · doi:10.1016/b978-1-4557-3383-5.00052-x · Cited by 781
Nutrients, foods, and colorectal cancer prevention
Song, M., Garrett, W. S., & Chan, A. T. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.12.035 · Cited by 700
Chemistry and biology of vitamin E
Schneider, C. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200400049 · Cited by 542
A review of the epidemiological evidence for the ‘antioxidant hypothesis’
Stanner, S., Hughes, J., Kelly, C., & Buttriss, J. (2004) · Public Health Nutrition · doi:10.1079/phn2003543 · Cited by 534
Gaziano, J. M., Glynn, R. J., Christen, W. G., Kurth, T., Belanger, C., MacFadyen, J., Bubes, V., Manson, J. E., Sesso, H. D., & Buring, J. E. (2009) · JAMA · doi:10.1001/jama.2008.862 · Cited by 518
Antioxidant Therapy: Current Status and Future Prospects
Firuzi, O., Miri, R., Tavakkoli, M., & Saso, L. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711803414368 · Cited by 468
Carotenoids and cardiovascular health
Voutilainen, S., Nurmi, T., Mursu, J., & Rissanen, T. H. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1265 · Cited by 463
Hsing, A. (2006) · Frontiers in Bioscience · doi:10.2741/1891 · Cited by 447
Fortmann, S. P., Burda, B. U., Senger, C. A., Lin, J. S., & Whitlock, E. P. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-12-201312170-00729 · Cited by 442
Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Meyskens, F. L., Omenn, G. S., Valanis, B., & Williams, J. H. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh320 · Cited by 430
Qiao, Y.-L., Dawsey, S. M., Kamangar, F., Fan, J.-H., Abnet, C. C., Sun, X.-D., Johnson, L. L., Gail, M. H., Dong, Z.-W., Yu, B., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp037 · Cited by 324
Carotenoids: potential allies of cardiovascular health?
Maria, A. G., Graziano, R., & Nicolantonio, D. (2015) · Food & Nutrition Research · doi:10.3402/fnr.v59.26762 · Cited by 323
Changing demography of prostate cancer in Asia
Sim, H. G., & Cheng, C. W. S. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.033 · Cited by 319
Dietary Antioxidants and Human Cancer
Borek, C. (2004) · Integrative Cancer Therapies · doi:10.1177/1534735404270578 · Cited by 302
Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007176 · Cited by 302
Druesne‐Pecollo, N., Latino‐Martel, P., Norat, T., Barrandon, E., Bertrais, S., Galan, P., & Hercberg, S. (2010) · International Journal of Cancer · doi:10.1002/ijc.25008 · Cited by 283
Patel, C. J., Burford, B., & Ioannidis, J. P. A. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.05.029 · Cited by 274
Marine Carotenoids against Oxidative Stress: Effects on Human Health
Gammone, M., Riccioni, G., & D'Orazio, N. (2015) · Marine Drugs · doi:10.3390/md13106226 · Cited by 270
Cancer-preventive activities of tocopherols and tocotrienols
Ju, J., Picinich, S. C., Yang, Z., Zhao, Y., Suh, N., Kong, A.-N., & Yang, C. S. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp205 · Cited by 262
Diet, nutrition, and cancer: past, present and future
Mayne, S. T., Playdon, M. C., & Rock, C. L. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.24 · Cited by 260
Clinical trials of antioxidants as cancer prevention agents: Past, present, and future
Goodman, M., Bostick, R. M., Kucuk, O., & Jones, D. P. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.018 · Cited by 255
Supplemental vitamins and minerals for CVD prevention and treatment
Jenkins, D. J. A., Spence, J. D., Giovannucci, E. L., Kim, Y.-I., Josse, R., Vieth, R., Blanco Mejia, S., Viguiliouk, E., Nishi, S., Sahye-Pudaruth, S., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.020 · Cited by 251
Antioxidant supplements and mortality
Bjelakovic, G., Nikolova, D., & Gluud, C. (2013) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0000000000000009 · Cited by 234
Bairati, I., Meyer, F., Gelinas, M., Fortin, A., Nabid, A., Brochet, F., Mercier, J.-P., Tetu, B., Harel, F., Masse, B., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji095 · Cited by 232
Supplemental and Dietary Vitamin E, β-Carotene, and Vitamin C Intakes and Prostate Cancer Risk
Kirsh, V. A., Hayes, R. B., Mayne, S. T., Chatterjee, N., Subar, A. F., Dixon, L. B., Albanes, D., Andriole, G. L., Urban, D. A., & Peters, U. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj050 · Cited by 226
Chemoprevention of colorectal cancer: systematic review and economic evaluation
Cooper, K., Squires, H., Carroll, C., Papaioannou, D., Booth, A., Logan, R., Maguire, C., Hind, D., & Tappenden, P. (2010) · Health Technology Assessment · doi:10.3310/hta14320 · Cited by 218
Cancer prevention research — then and now
Bode, A. M., & Dong, Z. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2646 · Cited by 188
Bjelakovic, G., Nikolova, D., & Gluud, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074558 · Cited by 183
“Virtamo et al [110], 2003 2x2 29133 0 57 6.”
Schwingshackl, L., Boeing, H., Stelmach-Mardas, M., Gottschald, M., Dietrich, S., Hoffmann, G., & Chaimani, A. (2017) · Advances in Nutrition · doi:10.3945/an.116.013516 · Cited by 165
“The ATBC and CARET (Carotene and Retinol Efficacy Trial) studies indicated that b-carotene significantly increases the risk of lung cancer, by accelerating the progression in smokers and asbestos-exposed workers (80).”
Dietary carotenoids in cancer chemoprevention and chemotherapy: A review of emerging evidence
Saini, R. K., Keum, Y.-S., Daglia, M., & Rengasamy, K. R. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104830 · Cited by 164
Toxic phytochemicals and their potential risks for human cancer
Bode, A. M., & Dong, Z. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0160 · Cited by 140
Tanvetyanon, T., & Bepler, G. (2008) · Cancer · doi:10.1002/cncr.23527 · Cited by 122
“After the completion of the CARET and ATBC studies, the excess risk of lung cancer and its associated mortality either persisted insignificantly or decreased to the baseline risk after the discontinuation of beta-carotene.(21,22) The NCI has published its conclusions regarding the beta-carotene chemoprevention trials…”
MethodMiddha, P., Weinstein, S. J., Männistö, S., Albanes, D., & Mondul, A. M. (2019) · Nicotine & Tobacco Research · doi:10.1093/ntr/nty115 · Cited by 104
Self-citation
Metadata
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2003-07-23
- Volume
- 290
- Issue
- 4
- Pages
- 476
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2209432090
- Cited by
- 426
- References
- 0
- FWCI
- 16.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.